BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
81.99
-0.08 (-0.10%)
Aug 5, 2026, 4:00 PM EDT - Market closed
BridgeBio Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 879.89 | 570.12 | 681.1 | 392.59 | 414.62 | 393.95 |
Short-Term Investments | 60.3 | 17.36 | - | 58.95 | 95.23 | 442.89 |
Cash & Short-Term Investments | 940.19 | 587.48 | 681.1 | 451.54 | 509.85 | 836.84 |
Cash Growth | 73.92% | -13.74% | 50.84% | -11.44% | -39.07% | 37.84% |
Accounts Receivable | 205.23 | 139.44 | 4.72 | 1.75 | - | - |
Other Receivables | - | - | - | - | 17.08 | 19.75 |
Total Trade Receivables | 205.23 | 139.44 | 4.72 | 1.75 | 17.08 | 19.75 |
Inventory | 32.98 | 26.75 | - | - | - | - |
Other Current Assets | 62.91 | 44.07 | 34.87 | 24.31 | 21.92 | 32.27 |
Total Current Assets | 1,241 | 797.75 | 720.69 | 477.59 | 548.85 | 888.86 |
Net Property, Plant & Equipment | 22.17 | 13.52 | 12.78 | 19.84 | 25.25 | 45.97 |
Other Intangible Assets | 27.36 | 28.08 | 23.93 | 26.32 | 28.71 | 44.93 |
Long-Term Investments | 61.53 | 79.97 | 143.75 | - | - | - |
Other Long-Term Assets | 18.62 | 16.71 | 18.2 | 22.63 | 20.22 | 33.03 |
Total Assets | 1,371 | 936.03 | 919.34 | 546.38 | 623.04 | 1,013 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 29.06 | 36.23 | 9.62 | 10.66 | 11.56 | 11.88 |
Accrued Expenses | 93.77 | 118.14 | 92.6 | 87.14 | 71.06 | 81.18 |
Current Portion of Long-Term Debt | 547.48 | - | - | - | - | - |
Current Portion of Leases | 4.44 | 6.19 | 4.51 | 4.13 | 3.68 | 4.94 |
Unearned Revenue | 6.12 | 7.19 | 14.6 | 6.1 | 8.16 | - |
Other Current Liabilities | 135.51 | 120.22 | 33.07 | 35.83 | 26.98 | 37.07 |
Total Current Liabilities | 816.37 | 287.97 | 154.4 | 143.84 | 121.43 | 135.07 |
Long-Term Debt | 1,926 | 1,852 | 1,721 | 1,727 | 1,708 | 1,704 |
Long-Term Leases | 14.22 | 3.81 | 4.7 | 8.98 | 12.27 | 17.43 |
Other Long-Term Liabilities | 883.19 | 868.35 | 496.47 | 9.36 | 26.64 | 22.07 |
Total Long-Term Liabilities | 2,823 | 2,725 | 2,223 | 1,745 | 1,747 | 1,743 |
Total Liabilities | 3,640 | 3,013 | 2,377 | 1,889 | 1,868 | 1,878 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.2 | 0.2 | 0.2 | 0.18 | 0.16 | 0.15 |
Treasury Stock | -405.78 | -323.28 | -275 | -275 | -275 | -275 |
Additional Paid-in Capital | 2,112 | 2,058 | 1,903 | 1,481 | 938.7 | 841.53 |
Accumulated Other Comprehensive Income | -0.01 | 0.01 | 0.01 | 0.03 | -0.33 | -0.13 |
Retained Earnings | -3,985 | -3,821 | -3,096 | -2,561 | -1,918 | -1,437 |
Total Common Shareholders' Equity | -2,278 | -2,087 | -1,468 | -1,354 | -1,255 | -870.41 |
Minority Interest | 9.49 | 10.03 | 10.29 | 11.72 | 9.69 | 4.84 |
Shareholders' Equity | -2,269 | -2,077 | -1,458 | -1,343 | -1,245 | -865.58 |
Total Liabilities & Equity | 1,371 | 936.03 | 919.34 | 546.38 | 623.04 | 1,013 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,492 | 1,862 | 1,731 | 1,740 | 1,724 | 1,726 |
Net Cash (Debt) | -1,552 | -1,275 | -1,049 | -1,288 | -1,214 | -889.33 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -8.05 | -6.66 | -5.64 | -7.91 | -8.23 | -6.16 |
Book Value | -2,278 | -2,087 | -1,468 | -1,354 | -1,255 | -870.41 |
Book Value Per Share | -11.82 | -10.89 | -7.89 | -8.32 | -8.51 | -6.03 |
Tangible Book Value | -2,306 | -2,115 | -1,492 | -1,381 | -1,283 | -915.35 |
Tangible Book Value Per Share | -11.97 | -11.04 | -8.02 | -8.48 | -8.70 | -6.34 |